EPHENIN IMPROVED

Main information

  • Trade name:
  • EPHENIN IMPROVED 50 TAB
  • Pharmaceutical form:
  • TAB
  • Composition:
  • 50
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • EPHENIN IMPROVED 50 TAB
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

28-6-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on developments in the romaine outbreak investigation, recent outbreaks and the use of modern tools to advance food safety

Statement from FDA Commissioner Scott Gottlieb, M.D., on developments in the romaine outbreak investigation, recent outbreaks and the use of modern tools to advance food safety

Being able to identify outbreaks is key to being able to take quick action to prevent additional illnesses and find the source of the contamination. In recent years, the FDA and the Centers for Disease Control and Prevention (CDC) have advanced new tools that make it easier and faster to identify outbreaks of human illness and to link them back to the food source that is the culprit responsible for the illnesses. But our improved ability to spot outbreaks has also caused some to question whether we are e...

FDA - U.S. Food and Drug Administration

5-9-2016

Improved access to patient data in clinical trials for monitors and GCP inspectors

Improved access to patient data in clinical trials for monitors and GCP inspectors

The Danish Medicines Agency's inspectors have direct access to health information in patient records in all clinical trials on medicinal products notified from 1 July 2016.

Danish Medicines Agency

3-8-2015

Increase in clinical trial applications

Increase in clinical trial applications

An increasing number of clinical trial applications, improved production and assessment performance, but also longer assessment times.

Danish Medicines Agency

13-5-2011

Danish Pharmacovigilance Update, April 2011

Danish Pharmacovigilance Update, April 2011

In this issue of Danish Pharmacovigilance Update, read about a new contraindication for Telzir® (fosamprenavir) for HIV treatment, reports of blood clots from the use of Vivaglobin®, and new, improved e-forms for reporting suspected adverse reactions and much more.

Danish Medicines Agency

6-6-2018

News and press releases:  Towards improved safety monitoring of veterinary medicines

News and press releases: Towards improved safety monitoring of veterinary medicines

Companies are encouraged to report all suspected side effects in EudraVigilance Veterinary

Europe - EMA - European Medicines Agency